Evidence map›Paper›PMID 35477356›Full record

ArticleBMC cancer2022

Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: pathways and patient characteristics.

Charlotte Hyldgaard, Christian Trolle, Stefan Markus Walbom Harders, Henriette Engberg, Torben Riis Rasmussen, Henrik Møller

Abstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Progress against lung cancer, Denmark, 2008-2022.Acta oncologica (Stockholm, Sweden) · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. How do the UK's guidelines on imaging for suspected lung cancer compare with other countries?The British journal of general practice : the journal of the Royal College of General Practitioners · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Charlotte HyldgaardDiagnostic Centre, Silkeborg Regional Hospital, Falkevej 1-3, Silkeborg, Denmark. chahyl@rm.dk.
Christian TrolleDiagnostic Centre, Silkeborg Regional Hospital, Falkevej 1-3, Silkeborg, Denmark.
Stefan Markus Walbom HardersDiagnostic Centre, Silkeborg Regional Hospital, Falkevej 1-3, Silkeborg, Denmark.
Henriette EngbergThe Danish Clinical Quality Program and Clinical Registries (RKKP), Aarhus, Denmark.
Torben Riis RasmussenDepartment of Respiratory Disease and Allergy, Aarhus University Hospital, Aarhus, Denmark.
Henrik MøllerThe Danish Clinical Quality Program and Clinical Registries (RKKP), Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAt Silkeborg Regional Hospital, Denmark, the number of stage IA lung cancer increased after implementation of increased use of CT investigations and a corresponding reduction in chest X-ray. The aim of the present study was to understand the changes in referral pathways, patient characteristics and imaging procedures behind the observed increase in early-stage lung cancer.

methodsThe referral and imaging pathways for all patients diagnosed with lung cancer in 2013-2018 were described based on manually curated information from the electronic health care systems and staging information from the Danish Lung Cancer Registry. We compared the clinical characteristics of patients diagnosed in 2013-2015 and in 2016-2018 after implementation of a change in the use of low dose CT scan (LDCT). For patients diagnosed in 2016-2018, stage IA lung cancer were compared to higher stages using univariable logistic regression analysis.

resultsFive hundred and forty-seven patients were diagnosed with lung cancer in 2013-2018. Stage IA constituted 13.8% (34/247) in 2013-2015, and 28.3% (85/300) in 2016-2018. Stage IA patients in 2016-2018 were characterised by more comorbidity, fewer packyears and tended to be older than patients with higher stages. In 2016-2018, the largest proportion of stage IA patients (55%) came from within-hospital referrals. The majority of these lung cancers were detected due to imaging procedures with other indications than suspicion of lung cancer. The proportion of stage IA increased from 12% (12/99) to 36% (47/129) (p < 0.001) for hospital referrals and from 17% (22/129) to 23% (38/165) for GP referrals (p = 0.21). The imaging procedures contributing to the increase in stage IA was contrast enhanced CT (22%¸11/51), LDCT (35%; 18/51) and X-ray followed by LDCT (25%; 13/51).

conclusionThe increased access to LDCT for patients referred from general practice and the increased hospital requested CT activity resulted in an increase in the number of stage IA lung cancers. Incidental findings on imaging performed for diagnostic purposes unrelated to suspicion of lung cancer contributed a large proportion of the increase.

Indexed as

General PracticeLung NeoplasmsHumansReferral and ConsultationTomography, X-Ray ComputedCT imagingDiagnosticsLung cancer

Identifiers

PMID35477356
PMCPMC9047294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.